Zaneka Pharmaceuticals Private Limited

Zaneka Pharmaceuticals Private Limited - pharma in Haridwar, Uttarakhand, India. FY 2026 financials & compliance.
CIN U24231UR1999PTC001430 Incorporated 26 May 1999 ROC Uttarakhand HQ Haridwar, Uttarakhand, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹4.17 Cr
▼ 3% YoY
Net profit · FY 2025
₹6.37 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹14.74 Lakh
EBITDA margin 3.5%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹90 Lakh
Satisfied ₹22 Lakh
Company age
27 yrs
Est. 1999
Employees · EPFO
17
Provident fund records

About Zaneka Pharmaceuticals Private Limited

Data last updated:

Zaneka Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24231UR1999PTC001430. Its GSTIN is 05AAACZ1224A1Z3 (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Shifali and Satish Chand Virmani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 120 Dwarika Vihar Salempur Mehdood Bahadrabad, Haridwar, Uttarakhand, India – 249402.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.17 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹6.37 Lakh (net margin 1.5%) and EBITDA of ₹14.74 Lakh (EBITDA margin 3.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.

The company has about 17 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Zaneka Pharmaceuticals. As per MCA filings, the company has open charges of ₹90 Lakh and satisfied charges of ₹22 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.

Zaneka Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0011501). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zanekapharma.com.

Company details

CIN U24231UR1999PTC001430
Registration Number 001430
Incorporation Date 26 May 1999
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-06-0011501

CIN history

Zaneka Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231DL1999PTC099952. The current CIN is U24231UR1999PTC001430, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231UR1999PTC001430Current
U24231DL1999PTC099952Previous

Recognitions & Rankings of Zaneka Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UK-06-0011501

Contact details

Zaneka Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand. Its website is zanekapharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    120 Dwarika Vihar Salempur Mehdood Bahadrabad, Haridwar, Uttarakhand, India – 249402
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Zaneka Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Zaneka Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Zaneka Pharmaceuticals operates one associated brand: Zaneka Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical company offering a range of high-quality pharmaceutical products.zanekapharma.com

Business activity

The main business activity of Zaneka Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Zaneka Pharmaceuticals Private Limited, buy the company report.

Financials of Zaneka Pharmaceuticals Private Limited

FY 2025 filings available

Zaneka Pharmaceuticals Private Limited reported revenue of ₹4.17 Cr (down 3% YoY) for FY 2025.

Revenue · FY 2025
₹4.17 Cr ▼ 3%
Net profit · FY 2025
₹6.37 Lakh margin 1.5%
EBITDA · FY 2025
₹14.74 Lakh margin 3.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 3%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 1%
5 years · compounded
▼ 18%

Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 3% fall in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹14.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.37 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.5%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zaneka Pharmaceuticals Private Limited, buy the company report.

Board of directors of Zaneka Pharmaceuticals Private Limited

Zaneka Pharmaceuticals has 8 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
ShifaliDirector30 Jun 201115 Years 4 MonthsCurrent
Satish Chand VirmaniDirector30 Jun 201115 Years 4 MonthsCurrent
Amit VirmaniDirector30 Jun 201115 Years 4 MonthsCurrent
Shantanu VirmaniDirector30 Jun 201115 Years 4 MonthsCurrent
Ashu VirmaniDirector20 Jul 20224 Years 4 MonthsCurrent
Ashish VirmaniDirector26 May 199927 Years 5 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Zaneka Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Morsef Pharmaceuticals Private Limited₹4.18 Cr (FY 2025)-7.0%Mumbai, Maharashtra, India
Fab Pharmaceuticals Private Limited₹4.18 Cr (FY 2025)-29.0%Bangalore, Karnataka, India
Zaneka Pharmaceuticals Private Limitedthis company₹4.17 Cr (FY 2025)₹6.37 Lakh1.5%-3.0%17Haridwar, Uttarakhand, India
Adalbert Healthcare Private Limited₹4.16 Cr (FY 2023)6.0%Mira Road, Maharashtra, India
Neutraciaa Lifesciences Private Limited₹4.16 Cr (FY 2024)-11.0%Siliguri, West Bengal, India

To see the full peer comparison of Zaneka Pharmaceuticals Private Limited, buy the company report.

Auditor

Zaneka Pharmaceuticals Private Limited is audited by APV & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
APV & ASSOCIATESFY 2023123143W

Shareholding

The shareholding of Zaneka Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Zaneka Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹90 Lakh
Satisfied charges
₹22 Lakh
Breakdown by lending institutions
Axis Bank Limited₹0.50 Cr
Oriental Bank of Commerce₹0.40 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Feb 2021100428225Axis Bank Limited₹50 LakhOpen
27 Jan 201510570213Oriental Bank of Commerce₹40 LakhOpen
23 Jan 200810090955State Bank of India₹20 LakhSatisfied
05 Feb 200390037845State Bank of India₹2 LakhSatisfied

To see the full charge records of Zaneka Pharmaceuticals Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Zaneka Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Zaneka Pharmaceuticals Private Limited has a workforce of 17 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
17
Active EPFO establishments
1
Employee growth
-22.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2717
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Zaneka Pharmaceuticals Private Limited, buy the company report.

GST

Zaneka Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
05AAACZ1224A1Z3UttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Zaneka Pharmaceuticals Private Limited, buy the company report.

Recent activity

Zaneka Pharmaceuticals Private Limited has 14 board changes on record since 1999: 8 appointments and 6 cessations. The latest: Ashu Virmani ceased to be Additional Director on 30 Sep 2022.

AGM
Zaneka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zaneka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Ceased
Ashu Virmani ceased to be Additional Director.
Appointed
Ashu Virmani was appointed as Director.
Ceased
Manju Virmani ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100428225 was registered on 05 Feb 2021.
Ceased
Indu Batra ceased to be Additional Director.
Appointed
Indu Batra was appointed as Director.
Ceased
Kanta Batra ceased to be Director.
Charges
A charge registered on 23 Jan 2008 via Charge ID 10090955 with State Bank Of India was fully satisfied on 23 Feb 2015.
Charges
A charge registered on 05 Feb 2003 via Charge ID 90037845 with State Bank Of India was fully satisfied on 23 Feb 2015.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 0.40 Cr with Charge ID 10570213 was registered on 27 Jan 2015.

11 earlier events are in the company report.

Frequently asked questions

Zaneka Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 1999 (27+ years old) and is registered under CIN U24231UR1999PTC001430.

Zaneka Pharmaceuticals has 8 current directors:

The latest financial statements of Zaneka Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Zaneka Pharmaceuticals is 05AAACZ1224A1Z3, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Zaneka Pharmaceuticals is U24231UR1999PTC001430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zaneka Pharmaceuticals has 2 court cases on record: 2 filed against it.

Zaneka Pharmaceuticals was incorporated on 26 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Uttarakhand.

The peers of Zaneka Pharmaceuticals by revenue are Morsef Pharmaceuticals Private Limited, Fab Pharmaceuticals Private Limited, Adalbert Healthcare Private Limited, Neutraciaa Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Ashu Virmani ceased to be Additional Director on 30 Sep 2022. Ashu Virmani was appointed as Director on 20 Jul 2022. Manju Virmani ceased to be Director on 20 Jul 2022. Zaneka Pharmaceuticals has 14 board changes on record in total.

Yes, Zaneka Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0011501).

Zaneka Pharmaceuticals can be reached through the website zanekapharma.com. Its registered office is in Haridwar, Uttarakhand, India.